Cytokines as mediators of depression: what can we learn from animal studies? - PubMed (original) (raw)
Review
Cytokines as mediators of depression: what can we learn from animal studies?
Adrian J Dunn et al. Neurosci Biobehav Rev. 2005.
Abstract
It has recently been postulated that cytokines may cause depressive illness in man. This hypothesis is based on the following observations: 1. Treatment of patients with cytokines can produce symptoms of depression; 2. Activation of the immune system is observed in many depressed patients; 3. Depression occurs more frequently in those with medical disorders associated with immune dysfunction; 4. Activation of the immune system, and administration of endotoxin (LPS) or interleukin-1 (IL-1) to animals induces sickness behavior, which resembles depression, and chronic treatment with antidepressants has been shown to inhibit sickness behavior induced by LPS; 5. Several cytokines can activate the hypothalamo-pituitary-adrenocortical axis (HPAA), which is commonly activated in depressed patients; 6. Some cytokines activates cerebral noradrenergic systems, also commonly observed in depressed patients; 7. Some cytokines activate brain serotonergic systems, which have been implicated in major depressive illness and its treatment. The evidence for each of these tenets is reviewed and evaluated along with the effects of cytokines in classical animal tests of depression. Although certain sickness behaviors resemble the symptoms of depression, they are not identical and each has distinct features. Thus the value of sickness behavior as an animal model of major depressive disorder is limited, so that care should be taken in extrapolating results from the model to the human disorder. Nevertheless, the model may provide insight into the etiology and the mechanisms underlying some symptoms of major depressive disorder. It is concluded that immune activation and cytokines may be involved in depressive symptoms in some patients. However, cytokines do not appear to be essential mediators of depressive illness.
Similar articles
- [Immune activation and depression in the elderly].
Maas DW, Westendorp RG, van der Mast RC. Maas DW, et al. Ned Tijdschr Geneeskd. 2008 Jun 21;152(25):1413-7. Ned Tijdschr Geneeskd. 2008. PMID: 18624003 Review. Dutch. - [Antidepressants and cytokines--clinical and experimental studies].
Obuchowicz E, Marcinowska A, Herman ZS. Obuchowicz E, et al. Psychiatr Pol. 2005 Sep-Oct;39(5):921-36. Psychiatr Pol. 2005. PMID: 16358592 Review. Polish. - Unkind cytokines: current evidence for the potential role of cytokines in immune-mediated depression.
Pucak ML, Kaplin AI. Pucak ML, et al. Int Rev Psychiatry. 2005 Dec;17(6):477-83. doi: 10.1080/02646830500381757. Int Rev Psychiatry. 2005. PMID: 16401546 Review. - Depression and immunity: inflammation and depressive symptoms in multiple sclerosis.
Gold SM, Irwin MR. Gold SM, et al. Neurol Clin. 2006 Aug;24(3):507-19. doi: 10.1016/j.ncl.2006.03.007. Neurol Clin. 2006. PMID: 16877121 - Endotoxin- or pro-inflammatory cytokine-induced sickness behavior as an animal model of depression: focus on anhedonia.
De La Garza R 2nd. De La Garza R 2nd. Neurosci Biobehav Rev. 2005;29(4-5):761-70. doi: 10.1016/j.neubiorev.2005.03.016. Neurosci Biobehav Rev. 2005. PMID: 15878621 Review.
Cited by
- Psychoneuroimmunology of Mood Disorders.
Teixeira AL, Scholl JN, Bauer ME. Teixeira AL, et al. Methods Mol Biol. 2025;2868:49-72. doi: 10.1007/978-1-0716-4200-9_4. Methods Mol Biol. 2025. PMID: 39546225 Review. - Dual Approach to Depression: The Combined Efficacy of Intermittent Hypoxia and Fluoxetine in Modulating Behavioral and Inflammatory Responses.
Arboit F, Pereira GC, Fialho MFP, Becker G, Brum EDS, Pillat MM, Bochi GV, Portela LOC, Zanchet EM. Arboit F, et al. Biomedicines. 2024 Sep 18;12(9):2116. doi: 10.3390/biomedicines12092116. Biomedicines. 2024. PMID: 39335629 Free PMC article. - The association between neutrophil percentage-to-albumin ratio (NPAR) and depression among US adults: a cross-sectional study.
Wang L, Liu L, Liu X, Yang L. Wang L, et al. Sci Rep. 2024 Sep 19;14(1):21880. doi: 10.1038/s41598-024-71488-y. Sci Rep. 2024. PMID: 39300155 Free PMC article. - Body Image and Other Mood Vulnerabilities in Adolescents with Polycystic Ovary Syndrome and Metabolic Alterations.
Barbagallo F, Tiranini L, Placentino C, Mariacci G, Piccinino M, Cucinella L, Calogero AE, Nappi RE. Barbagallo F, et al. Children (Basel). 2024 Apr 26;11(5):521. doi: 10.3390/children11050521. Children (Basel). 2024. PMID: 38790516 Free PMC article. - Altered serum cytokines in patients with symptomatic disk herniation and depressive symptoms.
Bielewicz J, Daniluk B, Kamieniak P. Bielewicz J, et al. Front Neurosci. 2024 Apr 5;18:1366559. doi: 10.3389/fnins.2024.1366559. eCollection 2024. Front Neurosci. 2024. PMID: 38646609 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical